From Omics.org

Imbalances in DNA methylation and histone acetylation play a significant role in the development of cancer and other disease states such as inflammation. This provides a rationale for targeting epigenetic modification for drug discovery, as well as epigenomic profiling for biomarker and diagnostic development. This conference aims to highlight recent technologies facilitating profiling of methylation patterns, an understanding of HDAC and methyl transferase enzymes and biomarker identification to monitor drug effects, toxicity and effective dose for therapeutic intervention as well as diagnostic and prognostic tools in cancer and other disease states